The latest information on the most commonly prescribed drugs, their side effects, interactions, cost of therapy, and more. This reference delivers more than 20 new drug monographs, comprehensive updates reflecting the latest indications, usages, dosages, and precautions, and new FDA-approved indications for many drugs.
Key Features
Includes pertinent drug information for the most commonly dispensed drugs - over 850 generic and 2800 trade drugs - including non-FDA-approved uses.
Special Considerations for each drug include expert recommendations on therapy choice and administration, as well as relevant monitoring parameters and patient education guidelines.
Comparative drug tables help readers select the best drug form/therapy for patients.
A Therapeutic Index helps you quickly locate all potential therapies for a specific condition.
30 new drug monographs with complete information on each drug including: Aloxi, Amevive, Arimidex, Boniva, Casodex, Crestor, Cubicin, Elestat, Emcyt, Emend, Emtriva, Factive, Fareston, Fuzeon, Hexalen, Humira, Iprivask, Iressa, Levitra, Namenda, Pegasys, Raptiva, Relpax, Reyataz, Rituxan, Simulect, Somavert, Uroxatral, Velcade, Xolair, Zavesca
Provides comprehensive updates that incorporate the latest drugs, indications, usages, dosages, and precautions.
|
